This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
This short article and poster summary takes a deeper look into the 2021 IPOs for biotechnology-based therapeutics being developed by…
Article
8 months ago ●
5 mins read
What is it? DN-1289 is a CNS-penetrant, ATP-competitive DLK/LZK-selective dual kinase inhibitor intended to treat amyotrophic lateral sclerosis (ALS). The…
molecule
2 months ago ●
2 mins read
This article is Part 3 of a review series covering all of the initial public offerings for the biotech and…
Article
8 months ago ●
5 mins read
Toward an oral, once-daily non-peptide STT2 agonist. Paltusotine a novel oral somatostatin receptor 2 (SST2) agonist and Crinetics’ lead investigational…
molecule
2 months ago ●
5 mins read
There’s so many interesting new publications that don’t necessarily feature key molecules, but are helpful for drug hunters to know…
Article
9 months ago ●
6 mins read
What is it? SPR720 (pVXc-486) is an oral prodrug of a dual inhibitor of the bacterial DNA gyrase and topoisomerase…
molecule
2 months ago ●
5 mins read
Load More
